Background:The intertrochanteric fracture is one of the most frequent proximal femoral fractures, particularly in elderly people with osteoporotic bones. The gold standard therapy is internal fixation. In the patients unfit for surgery, however, it may be difficult. Aim of the study: to assess the clinical, radiological and complications outcome of trochanteric fracture in high risk patients treated by percutaneous external fixation. Patients and Methods: 20 high-risk patients hospitalized in Al Azhar University (Al-Hussien hospital) in addition to kafr El-Sheikh general hospital (April 2020 to March 2021), were treated with an external fixation done under local or regional anaesthesia. There were 8 men and 12 women. The mean average age was 70.80 (57-84) years. Results: The average operational time was 28.85 minutes. Hospital stay was brief, with an average of 1-2 days. No intra operative problems were found. Blood loss was low and none of the patients had any blood transfusion. All fractures healed within a average 12.05 weeks. Two patients developed a superficial pin-tract infection as a result of their treatment (10 percent ). Four (20%) of the patients had a shortening of the fracture. Revision fixation was performed on a patient with implant failure in 5% of cases without any complications. At 12 months, there were no patients with knee mobility restrictions. Pre-injury and 12-month functional scores for daily activities. Conclusion:Treatment of trochanteric fractures is safe and successful when externally fixed. Minimal anaesthetic and surgical risks; There was no blood loss; the hospital stay was brief; and the patient was able to leave the hospital quickly.; low morbidity and mortality; and a quick return to work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.